Business Description
RVL Pharmaceuticals PLC
NAICS : 325412
SIC : 2833
ISIN : IE00BF2HDL56
Description
Financial Strength
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.33 | |||||
Equity-to-Asset | 0.19 | |||||
Debt-to-Equity | 3.56 | |||||
Debt-to-EBITDA | -1.02 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | -12.29 | |||||
Beneish M-Score | -2.79 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -50.6 | |||||
3-Year EBITDA Growth Rate | 49.8 | |||||
3-Year EPS without NRI Growth Rate | -22.1 | |||||
3-Year Book Growth Rate | -38.5 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
9-Day RSI | 39.84 | |||||
14-Day RSI | 40.8 | |||||
6-1 Month Momentum % | -99.44 | |||||
12-1 Month Momentum % | -99.99 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.38 | |||||
Quick Ratio | 0.36 | |||||
Cash Ratio | 0.28 | |||||
Days Inventory | 27.4 | |||||
Days Sales Outstanding | 8.22 | |||||
Days Payable | 156.54 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -24.1 | |||||
Shareholder Yield % | -347679.09 |
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 74.73 | |||||
Operating Margin % | -118.02 | |||||
Net Margin % | -184.91 | |||||
FCF Margin % | -128.62 | |||||
ROE % | -145.57 | |||||
ROA % | -56.4 | |||||
ROIC % | -46.73 | |||||
ROC (Joel Greenblatt) % | -2470.53 | |||||
ROCE % | -62.05 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
EV-to-EBIT | -0.68 | |||||
EV-to-Forward-EBIT | -2.2 | |||||
EV-to-EBITDA | -0.69 | |||||
EV-to-Revenue | 1.06 | |||||
EV-to-Forward-Revenue | 1.02 | |||||
EV-to-FCF | -0.82 | |||||
Earnings Yield (Greenblatt) % | -147.06 | |||||
FCF Yield % | -431681.82 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:RVLPQ
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
RVL Pharmaceuticals PLC Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | 36.919 | ||
EPS (TTM) ($) | -0.7 | ||
Beta | -1.09 | ||
Volatility % | 118.3 | ||
14-Day RSI | 40.8 | ||
14-Day ATR ($) | 0.000018 | ||
20-Day SMA ($) | 0.0001 | ||
12-1 Month Momentum % | -99.99 | ||
52-Week Range ($) | 0.00001 - 0.96 | ||
Shares Outstanding (Mil) | 111.41 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 3 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
RVL Pharmaceuticals PLC Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
RVL Pharmaceuticals PLC Stock Events
Event | Date | Price($) | ||
---|---|---|---|---|
No Event Data |
RVL Pharmaceuticals PLC Frequently Asked Questions
What is RVL Pharmaceuticals PLC(RVLPQ)'s stock price today?
When is next earnings date of RVL Pharmaceuticals PLC(RVLPQ)?
Does RVL Pharmaceuticals PLC(RVLPQ) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |